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1. Introduction 
Recently, we have reported decreased cellular levels 
of CAMP-dependent protein kinase and CAMP-binding 
activity in neoplastic human mammary tissue [l] . 
Considering the sensitivity of the CAMP-protein kinase 
system to changes of CAMP, it was important to deter- 
mine intracellular levels of this cyclic nucleotide and to 
identify changes of phosphodiesterase and adenylyl 
cyclase activities, the two enzyme systems which 
directly regulate the intracellular CAMP metabolism. 
Recently, increased levels of CAMP were reported 
in human mammary carcinomas [2] . Our results show 
that neoplastic mammary tissues exhibit increased 
specific levels but decreased cellulsr levels of CAMP 
and cGMP. In addition, the cellular activities of 
adenylyl cyclase phosphodiesterase are significantly 
lower in neoplastic as compared with normal human 
breast tissues. 
Enzymes: Phosphodiesterase, cyclic nucleotide phospho- 
diesterase (EC 3.1.4.~); Adenylyl cyclase, adenyl cyclase 
(EC4.6.1.1.) 
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2. Materials and methods 
Cyclic AMP, cGMP and phosphodiesterase were 
obtained from Sigma Chemical Company. Cyclic 
[3H]AMP (37 Ci/mmol) was purchased from New 
England Nuclear. 12SI-Labeled cyclic AMP and “‘I- 
labeled cyclic GMP were obtained from Schwarz/Mann 
(Orangeburg, NY). 
Breast tissue specimens were obtained from patients 
during mastectomy, through biopsy (2-6 g tissue), and 
from patients undergoing plastic surgery. The specimens 
were frozen immediately after excision and stored at 
-70°C. For the various biochemical assays the breast 
tissue was pulverized in liquid nitrogen. For the CAMP- 
phosphodiesterase assay the powdered tissue was 
homogenized in 5 parts (w/v) of ice cold 10 mM Tris- 
HCl buffer, pH 7.4, containing 1.5 mM EDTA, 5 mM 
theophylline with a Polytron PT-20 (Brinkman Instr.). 
The homogenate was centrifuged for 90 min at 
105 000 X g. The supernatant fraction was assayed 
for CAMP-phosphodiesterase activities according to 
Thompson et al. [3]. 
To assay adenylyl cyclase activity the powdered 
tissue was homogenized for 1 min in 20 parts (w/v) of 
ice-cold 10 mM Tris-HCl buffer, pH 7.4, containing 
6 mM mercaptoethanol, using an Ultra Turrax (Janke 
and Kunkel, FRG) at position 6.5. The homogenate 
was filtered through 2 layers of nylon gauze and the 
filtrate was used for adenylyl cyclase assay, which was 
carried out according to Salomon et al. [4]. Protein was 
determined by the method of Lowry et al. [5 1. 
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Cyclic AMP was determined either by radio- 
immnuoassay [6] or by the competitive binding 
assay [7] using a CAMP-binding protein isolated by 
DEAE-cellulose chromatography of calf ovarian 
cytosol [8]. The specificity for CAMP was tested by 
treatment of representative samples with phospho- 
diesterase (Sigma) which destroyed all of the bind- 
ing activity. 
3.4. Adenylyl cyclase 
The adenylyl cyclase activities of mammary tissue 
at various stages of dysplasia (MI-F, MI, MII) was 
compared with 13 carcinomas (table 2). Specific 
adenylyl cyclase activities are significantly elevated in 
simple, proliferative dysplasia and carcinoma tissue as 
compared to normal tissue (MI-F). 
Morphological characterization and histometry 
was carried out as previously described [ 13 . The 
tissues were divided in 5 categories: MI-F (simple dys- 
plasia with extensive tibrosis), MI (simple dysplasia), 
MI1 (proliferative dysplasia), CA (primary carcinoma) 
and FA (tibroadenoma). MI-F was regarded as normal 
tissue [l] . 
3. Results 
3.1. Cyclic AMP levels 
Cyclic AMP was analyzed in 121 tissue specimens 
and the results are shown in fig.1 A. Cyclic AMP per 
gram tissue was significantly @<O.OOl) higher in CA 
than in normal or dysplastic tissue. In tibroadenomas 
the CAMP concentrations were slightly lower @<0.05) 
than in carcinomas. It is of interest that in MI and 
MI1 approx. 20% of the tissue samples examined were 
responsible for the relatively large standard deviations. 
Also, 6 out of 24 tissue samples of the CA-group 
exhibited CAMP levels greater than 1200 pmol/g 
tissue. 
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3.2. Cyclic GMP-levels 
In 70 tissue specimens cGMP (pmol/g tissue) was 
measured and the results are shown in fig.lB. In analogy 
to CAMP, thelevels of cGMP were significantly elevated 
in carcinoma as compared to normal tissue (jKO.002) 
and simple dysplasia (p<O.Ol). 
3.3. Phosphodiesterase Ml-F Ml hill CA FA 
Phosphodiesterase activities of crude cytosol 
fractions measured at two substrate concentrations 
(6 X 10-s and 1 X 10 -6 M CAMP) are shown in 
table 1. At both substrate concentrations phospho- 
diesterase activities were significantly increased in 
carcinoma tissues as compared to MI-F. At the lower 
substrate concentration phosphodiesterase activity is 
significantly higher in MII, CA and FA. 
Fig.1. Cyclic AMP (A) and cCMP levels (B) in mammary 
tissue obtained from normal tissue (MI-F), simple (MI) and 
proliferative dysplasia (MD), fibroadenoma (FA) and neo- 
plastic tissue (CA). Each bar represents the mean * SD. 
Number within bar indicates number of tissue specimens 
analyzed. *Significantly different @<O.OOl) as compared 
to MI-F **Significantly different @<0.002) as compared 
to MI-F. 
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Table 1 
Cyclic phosphodiesterase activity in human breast tissue 
Tissue Number 
of 
patients 
Phosphodiesterase activity 
(pmol CAMP hydrolyzed/mg protein) 
6 X lo-’ M CAMP lo+ M CAMP 
Simple dysplasia with 
extensive fibrosis (MI-F) 35 2.4 + 0.8 (18) 11.7 f 6.7 (17) 
Simple dysplasia (MI) 43 2.0 * 1.0 (13) 10.0 + 7.0 (30) 
Proliferative dysplasia (MD) 36 3.6 f 1.4 (25)a 13.7 + 8.4 (11) 
Carcinoma (CA) 42 4.0 f 1.4 (25)b 21.5 f 18.6 (13) 
Fibroadenoma (FA) 13 6.0 f 1.5 (9)’ 13.8 f 12.3 (4) 
a p<o.o2; 
bp<0.005; 
’ p<O.OOl as compared to MI-F. Number of individual tissues examined in parentheses 
The phosphodiesterase activity was measured in crude cytosol fractions at two different 
substrate concentrations (6 X lo-’ and 1 X 10s6 M CAMP). Each value is the mean * SD 
3 S. Relative cellular levels of CAMP - and cGMP- 
phosphodiesterase and adenylyl cyclase 
The above results are presented as specific enzymatic 
activities or cyclic nucleotide levels per unit weight of 
tissue protein and do not take into account the marked 
variations of cellular densities within the various histo- 
pathological groups. When the previously described 
histometric values [l] are considered the relative 
cellular levels of the cyclic nucleotides (flg.2) phospho- 
diesterase and adenylyl cyclase (table 2) can be 
obtained. Such a correlation reveals markedly lower 
levels of cellular adenylyl cyclase activity in CA 
(table 2) and lower levels of CAMP (2-3-fold) and 
cGMP (4-fold) in CA and MI1 tissues (fig.2) as compared 
to normal tissue. Similarly the relative cellular phos- 
phodiesterase activities were 3-4-fold lower in CA 
and MI1 than in normal tissue (fig.3). 
Table 2 
Adenylyl cyclase activity in human breast tissue 
Tissue Number 
of 
patients 
Adenyl cyclase activity 
pmol CAMP formed/g tissue/mm rel. activity/cell 
Simple dysplasia with 8 3162 127 421 r 221 
extensive fibrosis (MI-F) 
Simple dysplasia (MI) 11 959 f 590a 530 c 254 
Proliferative dysplasia 12 962 + 658a 247 f 128 
Carcinoma (CA) 13 1727*1535a 308 f 247 
a p<O.Ol as compared to MI-F 
The adenylyl cyclase assay was carried out with crude homogenate in the presence of 8 X lo-” M NaF 
as effector [ 121. Each value is the mean f SD. The adenylyl cyclase activity per cell was calculated by 
dividing the specific activity through the cellular density [l] of each individual histopathologlcal group 
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CAMP 
MI-F MI MII CA FA 
Fig.2. Relative cellular levels of CAMP and cGMP. The 
results were obtained after dividing the individual, specific 
CAMP and cGMP levels by the respective cellular density 
(MI-F, 0.75 t 0.49; MI, 1.81 i 0.64; MII, 3.89 f 1.43; 
CA, 5.60 f 2.29; FA, 4.59 f. 1.16 cells/1000 pm*). 
4. Discussion 
The results presented indicate that CAMP and 
cGMP levels as well as phosphodiesterase and adenylyl 
cyclase levels are significantly elevated in neoplastic 
human breast tissue provided the values are compared 
per unit weight of tissue or per unit weight of cellular 
protein. However, these values do not take into account 
the relative cellular densities which are known to 
characterize the various morphological classes of human 
breast tissue [l] . When these biochemical data are 
expressed as relative cyclic nucleotide levels and enzy- 
matic activities per cell, the neoplastic tissues are 
characterized by markedly lower cyclic nucleotide 
and enzymatic activities. 
0 6x10-*H 
MI-F MI MJI 
(17) (30) (11) (?I Ifi 
Fig.3. Relative cellular activity of CAMP phosphodiesterase. 
These cellular activities were calculated as described in fig.2. 
Number of individual tissues examined in parentheses. 
In view of the changing morphological and bio- 
chemical characteristics of tumors, particularly changes 
of the cellular DNA and protein content, we believe 
that a correlation of cyclic nucleotide and enzymatic 
levels with the cellular density provides a meaningful 
way to compare and monitor biochemical changes 
during neoplastic transformation. Correlation of 
biochemical data with the cellular densities may, in 
fact, be used to resolve the controversy of previous 
findings in which both increases and decreases of 
cyclic nucleotide levels and of phosphodiesterase have 
been observed. 
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